HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 22, No 07, July 2018 – Water management- Technologies for biotech and pharmaceutical industries       » Why sunshine improves mood and makes us smarter       » SGD110 million lab to create healthier foods and sustainable biochemicals       » Entries open for the USD170,000 Ryman Prize       » Could the eye be the window to brain degeneration?       » High vitamin D levels linked to lower cholesterol in children      
FEATURES
The gift of life: 50 years of human heart transplant
On 3 December 1967, Christiaan Barnard performed the world’s first human heart transplant on 53-year-old Louis Washkansky at Groote Schuur Hospital in Cape Town, South Africa. Washkansky was a South African grocer suffering from congestive/severe heart failure. His donor was Denise Darvall, a 25-year-old woman, who was fatally injured in a car accident and declared brain dead at the same hospital Washkansky was admitted. With full permission from the donor’s family, Christiaan Barnard, head of the Department of Experimental Surgery at the Groote Schuur Hospital, performed the medical operation. He modified the technique which was initially developed by American surgeons, Norman Shumway and Richard Lower, who achieved the world’s first successful heart transplant in a dog, at Stanford University in California in 1958. After the successful heart transplant into Washkansky, he had drugs to suppress his immune system and prevent his body from rejecting the new heart. Washkansky died 18 days later from pneumonia. Despite this, the transplant was touted successful as Washkansky’s new heart had functioned normally until his death.

This year marks 50 years since the world’s first human-to-human heart transplantation. The biggest drawback in heart transplant has always been the same as it was before, and that is the lack of suitable donor organs. While in most countries, people express an interest in donating their organs after being declared brain dead, only a small percentage of people undergo circumstances where organ donation is possible.

This shortage is what drives the innovation to experiment with xenotransplantation, improving immunosuppressant drugs, and the development of artificial hearts or coronary assist devices. Ultimately, the key is in increasing the patients’ survival rates.

» Click here for full article

Click here for the complete issue.

NEWS CRUNCH  
news Shire, Microsoft and EURORDIS form Global Commission to accelerate time to diagnosis for children with rare diseases
news EmTech Asia explores future of life, humanity and economy
news Biology of Ageing II - Impactful Interventions
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  
COLUMNS  
Click here to receive APBN e-newsletters once a month!

APBN Editorial Calendar 2018
January:
Obesity / Outlook for 2018
February:
Searching for the fountain of youth
March:
Women in Science - Making a difference
April:
Digestive health in the 21st century - Trust your guts
May:
Dental health - The root to good health
June:
Cancer - Therapies and strategies for better patient outcomes
July:
Water management- Technologies for biotech and pharmaceutical industries
August:
Regenerative medicine / Biotech start ups
September:
Digital healthcare / 3D printing
October:
Bones / Breast cancer
November:
Liver health / Top science research nations & institutions
December:
AIDS / Breakthrough of the year/Emerging trends
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Lim Guan Yu
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2018 World Scientific Publishing Co Pte Ltd  •  Privacy Policy